Protease-antiprotease balance
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic |
| Language: | English |
| Published: |
London :
Henry Stewart Talks,
2012.
|
| Series: | Henry Stewart talks. Biomedical & life sciences collection. Advances in Chronic Obstructive Pulmonary Disease (COPD)
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 02364ngm a22003735a 4500 | ||
|---|---|---|---|
| 001 | 014242570-2 | ||
| 005 | 20141204020309.0 | ||
| 006 | m|||||o||c|||||||| | ||
| 008 | 121016s2012 enk|||||||||||o|||v|eng d | ||
| 035 | |a (HSTalks)HST3207_1_2_20141204 | ||
| 040 | |a UKHST |c UKHST | ||
| 040 | |a HSTalks |b eng |c HSTalks | ||
| 100 | 1 | |a Stockley, Robert A. |4 spk | |
| 245 | 1 | 0 | |a Protease-antiprotease balance |h [electronic resource] / |c Rob Stockley. |
| 246 | 3 | |a Protease antiprotease balance | |
| 260 | |a London : |b Henry Stewart Talks, |c 2012. | ||
| 300 | |a 1 streaming video file (39 min.) : |b digital, mono., SWF file, sd., col. | ||
| 490 | 1 | |a Advances in Chronic Obstructive Pulmonary Disease (COPD) : new mechanisms, management strategies and treatments | |
| 500 | |a Animated audio-visual presentation with synchronized narration. | ||
| 500 | |a Title from title frames. | ||
| 505 | 0 | |a Contents: Pathophysiology of COPD and Emphysema -- Carl-Bertil Laurell -- Alpha 1 antitrypsin deficiency -- Effects of neutrophil elastase -- Augmentation therapy -- Anti inflammatory effects -- Testing emphysema progression -- Emphysema with normal lung function -- Alternative approach for assessing emphysema -- The complexity of neutrophil biology -- Processes of neutrophil movement -- Elastase concentration change -- Quantum proteolytic events of neutrophils -- Destructive potential of neutrophils -- Chemotaxis -- Neutrophils and COPD -- Monitoring neutrophil elastase activity in vivo -- Elastase inhibitors -- Role of proteinases in emphysema -- The other neutrophil serine proteinases -- The smoking mouse -- Alveoli in smokers vs. non smokers -- Effects of TNF alpha polymorphisms -- The roles of MMPs. | |
| 650 | 0 | 0 | |a Emphysema, Pulmonary |x Pathophysiology. |
| 650 | 0 | 0 | |a Lungs |x Diseases, Obstructive |x Pathophysiology. |
| 650 | 0 | 0 | |a Protease inhibitors. |
| 650 | 0 | 0 | |a Smoking |x Adverse effects. |
| 650 | 0 | 2 | |a alpha 1-Antitrypsin Deficiency. |
| 650 | 0 | 2 | |a Leukocyte Elastase |x physiology. |
| 650 | 0 | 2 | |a Protease Inhibitors |x metabolism. |
| 650 | 0 | 2 | |a Pulmonary Disease, Chronic Obstructive |x physiopathology. |
| 650 | 0 | 2 | |a Pulmonary Emphysema |x physiopathology. |
| 650 | 0 | 2 | |a Smoking |x adverse effects. |
| 830 | 0 | |a Henry Stewart talks. |p Biomedical & life sciences collection. |p Advances in Chronic Obstructive Pulmonary Disease (COPD) | |
| 988 | |a 20141204 | ||
| 906 | |0 OCLC | ||